135 related articles for article (PubMed ID: 37260119)
1. Invited Commentary: Adjuvant Chemotherapy Is Beneficial in Stage III Ampullary Adenocarcinoma.
Premji AM; Donahue TR
J Am Coll Surg; 2023 Sep; 237(3):512-514. PubMed ID: 37260119
[No Abstract] [Full Text] [Related]
2. Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study.
Moekotte AL; Malleo G; van Roessel S; Bonds M; Halimi A; Zarantonello L; Napoli N; Dreyer SB; Wellner UF; Bolm L; Mavroeidis VK; Robinson S; Khalil K; Ferraro D; Mortimer MC; Harris S; Al-Sarireh B; Fusai GK; Roberts KJ; Fontana M; White SA; Soonawalla Z; Jamieson NB; Boggi U; Alseidi A; Shablak A; Wilmink JW; Primrose JN; Salvia R; Bassi C; Besselink MG; Abu Hilal M
Br J Surg; 2020 Aug; 107(9):1171-1182. PubMed ID: 32259295
[TBL] [Abstract][Full Text] [Related]
3. Oncologic outcomes in resected ampullary cancer: Relevance of histologic subtype and adjuvant chemotherapy.
Affi Koprowski M; Sutton TL; Brinkerhoff BT; Grossberg A; Sheppard BC; Mayo SC
Am J Surg; 2021 Jun; 221(6):1128-1134. PubMed ID: 33883071
[TBL] [Abstract][Full Text] [Related]
4. Adenocarcinoma of the ampulla of Vater: what treatment options are available?
Senatore FJ; Ynson ML; Dasanu CA
J Oncol Pharm Pract; 2015 Oct; 21(5):364-9. PubMed ID: 24906539
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of Ampullary Adenocarcinoma].
Shin DW
Korean J Gastroenterol; 2023 Oct; 82(4):159-170. PubMed ID: 37876255
[TBL] [Abstract][Full Text] [Related]
6. Current strategies in the therapeutic approach for adenocarcinoma of the ampulla of Vater.
Gaspar B; Beuran M; Paun S; Ganescu R; Hostiuc S; Negoi I
J Med Life; 2013 Sep; 6(3):260-5. PubMed ID: 24146684
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma of the ampulla of vater: a distinct disease entity?
Conlon KC
Ann Surg Oncol; 2003 Dec; 10(10):1136-7. PubMed ID: 14654467
[No Abstract] [Full Text] [Related]
8. Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater.
Krishnan S; Rana V; Evans DB; Varadhachary G; Das P; Bhatia S; Delclos ME; Janjan NA; Wolff RA; Crane CH; Pisters PW
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):735-43. PubMed ID: 17980502
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of lymph node status for patients with ampullary adenocarcinoma after radical resection followed by adjuvant treatment.
Kwon J; Kim K; Chie EK; Kim BH; Jang JY; Kim SW; Oh DY; Bang YJ
Eur J Surg Oncol; 2017 Sep; 43(9):1690-1696. PubMed ID: 28648977
[TBL] [Abstract][Full Text] [Related]
10. Nodal microinvolvement in patients with carcinoma of the papilla of vater receiving no adjuvant chemotherapy.
Bogoevski D; Chayeb H; Cataldegirmen G; Schurr PG; Kaifi JT; Mann O; Yekebas EF; Izbicki JR
J Gastrointest Surg; 2008 Nov; 12(11):1830-7; discussion 1837-8. PubMed ID: 18791769
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic hand-assisted pancreaticoduodenectomy: initial UK experience.
Ammori BJ
Surg Endosc; 2004 Apr; 18(4):717-8. PubMed ID: 15214369
[TBL] [Abstract][Full Text] [Related]
12. Preoperative chemotherapy of chemoradiotherapy for the treatment of adenocarcinoma of the pancreas and ampulla of Vater.
Hoffman JP; Cooper HS; Young NA; Pendurthi TK
J Hepatobiliary Pancreat Surg; 1998; 5(3):251-4. PubMed ID: 9880771
[TBL] [Abstract][Full Text] [Related]
13. [Present status and future prospect of the chemotherapy for ampullary cancer].
Imai H; Ishioka C
Nihon Rinsho; 2015 Mar; 73 Suppl 3():737-40. PubMed ID: 25857125
[No Abstract] [Full Text] [Related]
14. Ampullary cancer: an overview.
Ahn DH; Bekaii-Saab T
Am Soc Clin Oncol Educ Book; 2014; ():112-5. PubMed ID: 24857067
[TBL] [Abstract][Full Text] [Related]
15. A case of early depressed-type ampullary carcinoma treated by wire-guided endoscopic resection.
Katsinelos P; Kountouras J; Chatzimavroudis G; Zavos C; Paroutoglou G; Kotakidou R; Panagiotopoulou K; Papaziogas B
Surg Laparosc Endosc Percutan Tech; 2007 Dec; 17(6):533-7. PubMed ID: 18097317
[TBL] [Abstract][Full Text] [Related]
16. Ampullary cancer with pancreas divisum treated by endoscopic partial papillectomy: a case report.
Ito K; Noda Y; Fujita N; Horaguchi J; Kurose A; Sawai T
J Gastrointestin Liver Dis; 2011 Jun; 20(2):205-7. PubMed ID: 21725520
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of adjuvant therapy following curative surgery for periampullary adenocarcinoma.
Acharya A; Markar SR; Sodergren MH; Malietzis G; Darzi A; Athanasiou T; Khan AZ
Br J Surg; 2017 Jun; 104(7):814-822. PubMed ID: 28518410
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience.
Jin Z; Hartgers ML; Sanhueza CT; Shubert CR; Alberts SR; Truty MJ; Muppa P; Nagorney DM; Smyrk TC; Hassan M; Mahipal A
Eur J Surg Oncol; 2018 May; 44(5):677-683. PubMed ID: 29506768
[TBL] [Abstract][Full Text] [Related]
19. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial.
Neoptolemos JP; Moore MJ; Cox TF; Valle JW; Palmer DH; McDonald AC; Carter R; Tebbutt NC; Dervenis C; Smith D; Glimelius B; Charnley RM; Lacaine F; Scarfe AG; Middleton MR; Anthoney A; Ghaneh P; Halloran CM; Lerch MM; Oláh A; Rawcliffe CL; Verbeke CS; Campbell F; Büchler MW;
JAMA; 2012 Jul; 308(2):147-56. PubMed ID: 22782416
[TBL] [Abstract][Full Text] [Related]
20. Better outcome of XELOX chemotherapy in patients with advanced intestinal-type adenocarcinoma of the ampulla of Vater.
Kim HS; Shin SJ; Kim JH; Kim H; Choi HJ
Tohoku J Exp Med; 2013 Sep; 231(1):21-8. PubMed ID: 23994910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
